Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
June-2017 Volume 6 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2017 Volume 6 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa

  • Authors:
    • Natuhiko Shirota
    • Hidetsugu Nakayama
    • Sachica Shiraishi
    • Yoshihiko Usui
    • Keisuke Kimura
    • Tomohide Sanada
    • Norifumi Kennoki
    • Mitsuru Okubo
    • Hiroshi Goto
    • Koichi Tokuuye
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, Tokyo Medical University Hospital, Tokyo 160‑0023, Japan, Department of Ophthalmology, Tokyo Medical University Hospital, Tokyo 160‑0023, Japan
    Copyright: © Shirota et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 833-838
    |
    Published online on: May 5, 2017
       https://doi.org/10.3892/mco.2017.1241
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

The aim of the present study was to determine the optimal dose and optimal target volume for marginal zone lymphoma of the ocular adnexa. Between January, 2008 and December, 2013, 40 patients with histologically proven primary marginal zone lymphoma of the ocular adnexa who underwent radiotherapy at the Tokyo Medical University were evaluated. The prescribed dose was 30 Gy in 15 fractions to the iso‑center. Doses to the gross tumor volume (GTV), conjunctiva, bulbus oculi, retina and retrobulbar space were investigated, and the association between dose‑volume factors and clinical outcome was analyzed. The overall and local progression‑free survival rates at 3 and 5 years were 100% during a median observation period of 32 months. Two patients relapsed in the contralateral ocular adnexa. The progression‑free survival rates at 3 and 5 years were 100 and 93.3%, respectively. The mean dose was 2.0 and 1.9 Gy for targets receiving 95% of the GTV dose (D95). The minimum dose was 0.9‑2.0 Gy (median, 1.8 Gy). Thus, primary marginal zone lymphoma of the ocular adnexa favorably responded to lower doses of radiation, compared with prescribed doses to the iso‑center. A radiation dose of 27 Gy in 15 fractions at D95 of GTV appeared to be optimal.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Isaacson P and Wright DH: Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 52:1410–1416. 1983. View Article : Google Scholar : PubMed/NCBI

2 

Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumors: Pathology and Genetics of Tumorus of Haematopoietic and Lymphoid Tissues. IARC Press; Lyon: 2001

3 

Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma study group. Blood. 84:1361–1392. 1994.PubMed/NCBI

4 

Al-Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ and Go RS: Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998–2011. Am J Hematol. 90:790–795. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Smith A, Howell D, Patmore R, Jack A and Roman E: Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy research network. Br J Cancer. 105:1684–1692. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Ferreri AJ, Guidoboni M, Ponzoni M, de Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, et al: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 96:586–594. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, Harris NL and Ferry JA: Ocular adnexal lymphoma: Clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys. 57:1382–1391. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Graue GF, Finger PT, Maher E, Rocca D Della, Rocca R Della, Lelli GJ Jr and Milman T: Ocular adnexal lymphoma staging and treatment: American joint committee on cancer versus Ann Arbor. Eur J Ophthalmol. 23:344–355. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Jenkins C, Rose GE, Bunce C, Wright JE, Cree IA, Plowman N, Lightman S, Moseley I and Norton A: Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 84:907–913. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Parikh RR, Moskowitz BK, Maher E, Rocca D Della, Rocca R Della, Culliney B, Shapira I, Grossbard ML, Harrison LB and Hu K: Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy. Leuk Lymphoma. 56:1266–1270. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Zhou P, Ng AK, Silver B, Li S, Hua L and Mauch PM: Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys. 63:866–871. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Sumi M, et al: Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: A long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys. 88:650–654. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK, Wells W, Hodgson DC, Sun A, Simpson R and Tsang RW: Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: Efficacy and toxicity. Int J Radiat Oncol Biol Phys. 81:e659–e666. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Bayraktar S, Bayraktar UD, Stefanovic A and Lossos IS: Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): Single institution experience in a large cohort of patients. Br J Haematol. 152:72–80. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Tran KH, Campbell BA, Fua T, MacManus M, Ryan G, Chesson B and Wirth A: Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma. Leuk Lymphoma. 54:491–496. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY and Hahn JS: Orbital marginal zone B-cell lymphoma of MALT: Radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys. 65:228–233. 2006. View Article : Google Scholar : PubMed/NCBI

17 

Carbone PP, Kaplan HS, Musshoff K, Smithers DW and Tubiana M: Report of the committee on hodgkin's disease staging classification. Cancer Res. 31:1860–1861. 1971.PubMed/NCBI

18 

Stefanovic A and Lossos IS: Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 114:501–510. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R and Wirth A; International Lymphoma Radiation Oncology Group, : Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 92:11–31. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:679–694. 1989. View Article : Google Scholar : PubMed/NCBI

21 

Fasola CE, Jones JC, Huang DD, Le QT, Hoppe RT and Donaldson SS: Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys. 86:930–935. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Hoskin PJ, Kirkwood AA, Popova B, Smith P, Robinson M, Gallop-Evans E, Coltart S, Illidge T, Madhavan K, Brammer C, et al: 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): A randomised phase 3 non-inferiority trial. Lancet Oncol. 15:457–463. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Pfeffer MR, Rabin T, Tsvang L, Goffman J, Rosen N and Symon Z: Orbital lymphoma: Is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys. 60:527–530. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Kaushik M, Pulido JS, Schild SE and Stafford S: Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys. 84:1145–1150. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Kiesewetter B and Raderer M: Antibiotic therapy in nongastrointestinal MALT lymphoma: A review of the literature. Blood. 122:1350–1357. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shirota N, Nakayama H, Shiraishi S, Usui Y, Kimura K, Sanada T, Kennoki N, Okubo M, Goto H, Tokuuye K, Tokuuye K, et al: Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa. Mol Clin Oncol 6: 833-838, 2017.
APA
Shirota, N., Nakayama, H., Shiraishi, S., Usui, Y., Kimura, K., Sanada, T. ... Tokuuye, K. (2017). Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa. Molecular and Clinical Oncology, 6, 833-838. https://doi.org/10.3892/mco.2017.1241
MLA
Shirota, N., Nakayama, H., Shiraishi, S., Usui, Y., Kimura, K., Sanada, T., Kennoki, N., Okubo, M., Goto, H., Tokuuye, K."Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa". Molecular and Clinical Oncology 6.6 (2017): 833-838.
Chicago
Shirota, N., Nakayama, H., Shiraishi, S., Usui, Y., Kimura, K., Sanada, T., Kennoki, N., Okubo, M., Goto, H., Tokuuye, K."Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa". Molecular and Clinical Oncology 6, no. 6 (2017): 833-838. https://doi.org/10.3892/mco.2017.1241
Copy and paste a formatted citation
x
Spandidos Publications style
Shirota N, Nakayama H, Shiraishi S, Usui Y, Kimura K, Sanada T, Kennoki N, Okubo M, Goto H, Tokuuye K, Tokuuye K, et al: Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa. Mol Clin Oncol 6: 833-838, 2017.
APA
Shirota, N., Nakayama, H., Shiraishi, S., Usui, Y., Kimura, K., Sanada, T. ... Tokuuye, K. (2017). Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa. Molecular and Clinical Oncology, 6, 833-838. https://doi.org/10.3892/mco.2017.1241
MLA
Shirota, N., Nakayama, H., Shiraishi, S., Usui, Y., Kimura, K., Sanada, T., Kennoki, N., Okubo, M., Goto, H., Tokuuye, K."Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa". Molecular and Clinical Oncology 6.6 (2017): 833-838.
Chicago
Shirota, N., Nakayama, H., Shiraishi, S., Usui, Y., Kimura, K., Sanada, T., Kennoki, N., Okubo, M., Goto, H., Tokuuye, K."Target volume dose and clinical outcome in radiotherapy for primary marginal zone lymphoma of the ocular adnexa". Molecular and Clinical Oncology 6, no. 6 (2017): 833-838. https://doi.org/10.3892/mco.2017.1241
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team